236 related articles for article (PubMed ID: 14752209)
1. Effect of growth hormone replacement therapy on pituitary hormone secretion and hormone replacement therapies in GHD adults.
Hubina E; Mersebach H; Rasmussen AK; Juul A; Sneppen SB; Góth MI; Feldt-Rasmussen U
Horm Res; 2004; 61(5):211-7. PubMed ID: 14752209
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
3. Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement.
Schneider HJ; Oertel H; Murck H; Pollmächer T; Stalla GK; Steiger A
Psychoneuroendocrinology; 2005 Jan; 30(1):29-37. PubMed ID: 15358440
[TBL] [Abstract][Full Text] [Related]
4. Recombinant hGH replacement therapy and the hypothalamus-pituitary-thyroid axis in children with GH deficiency: when should we be concerned about the occurrence of central hypothyroidism?
Giavoli C; Porretti S; Ferrante E; Cappiello V; Ronchi CL; Travaglini P; Epaminonda P; Arosio M; Beck-Peccoz P
Clin Endocrinol (Oxf); 2003 Dec; 59(6):806-10. PubMed ID: 14974926
[TBL] [Abstract][Full Text] [Related]
5. The effect of the deterioration of insulin sensitivity on beta-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.
Rosenfalck AM; Fisker S; Hilsted J; Dinesen B; Vølund A; Jørgensen JO; Christiansen JS; Madsbad S
Growth Horm IGF Res; 1999 Apr; 9(2):96-105. PubMed ID: 10373342
[TBL] [Abstract][Full Text] [Related]
6. The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.
Elgzyri T; Castenfors J; Hägg E; Backman C; Thorén M; Bramnert M
Clin Endocrinol (Oxf); 2004 Jul; 61(1):113-22. PubMed ID: 15212653
[TBL] [Abstract][Full Text] [Related]
7. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
Wilhelm B; Kann PH
Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
[TBL] [Abstract][Full Text] [Related]
8. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
Columb B; Smethurst LE; Mukherjee A; Jostel A; Shalet SM; Murray RD
Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
[TBL] [Abstract][Full Text] [Related]
9. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
10. Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy.
Fernholm R; Thoren M; Hoybye C; Anderstam B; Pernow Y; Saaf M; Hall K
Growth Horm IGF Res; 2009 Jun; 19(3):206-11. PubMed ID: 18990596
[TBL] [Abstract][Full Text] [Related]
11. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
Oertel H; Schneider HJ; Stalla GK; Holsboer F; Zihl J
Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy.
Thorén M; Hilding A; Brismar T; Magnusson P; Degerblad M; Larsson L; Sääf M; Baylink DJ; Mohan S
J Bone Miner Res; 1998 May; 13(5):891-9. PubMed ID: 9610754
[TBL] [Abstract][Full Text] [Related]
13. [Growth hormone deficiency, its influence on bone mineral density and risk of osteoporotic fractures].
Kuzma M; Payer J
Cas Lek Cesk; 2010; 149(5):211-6. PubMed ID: 20629339
[TBL] [Abstract][Full Text] [Related]
14. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
15. Changes of thyroid function during long-term hGH therapy in GHD children. A possible relationship with catch-up growth?
Seminara S; Stagi S; Candura L; Scrivano M; Lenzi L; Nanni L; Pagliai F; Chiarelli F
Horm Metab Res; 2005 Dec; 37(12):751-6. PubMed ID: 16372229
[TBL] [Abstract][Full Text] [Related]
16. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
17. Effect of growth hormone deficiency and recombinant hGH (rhGH) replacement on the hypothalamic-pituitary-adrenal axis in children with idiopathic isolated GH deficiency.
Giavoli C; Bergamaschi S; Ferrante E; Ronchi CL; Lania AG; Rusconi R; Spada A; Beck-Peccoz P
Clin Endocrinol (Oxf); 2008 Feb; 68(2):247-51. PubMed ID: 17868384
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.
Svensson J; Finer N; Bouloux P; Bevan J; Jonsson B; Mattsson AF; Lundberg M; Harris PE; Koltowska-Häggström M; Monson JP;
Growth Horm IGF Res; 2007 Feb; 17(1):67-76. PubMed ID: 17223598
[TBL] [Abstract][Full Text] [Related]
19. Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults.
Cenci MC; Conceição FL; Soares DV; Spina LD; Brasil RR; Lobo PM; Michmacher E; Vaisman M
Metabolism; 2008 Jan; 57(1):121-9. PubMed ID: 18078869
[TBL] [Abstract][Full Text] [Related]
20. Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement.
Brooke AM; Kalingag LA; Miraki-Moud F; Camacho-Hübner C; Maher KT; Walker DM; Hinson JP; Monson JP
Clin Endocrinol (Oxf); 2006 Nov; 65(5):673-80. PubMed ID: 17054472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
